During the past decade, Empire Neurology, PC conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 10 clinical trials were completed, i.e. on average, 76.9% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 7 clinical trials were completed. i.e. 175% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Empire Neurology, PC" #1 sponsor was "Genentech, Inc." with 6 trials, followed by "Multiple Sclerosis Center of Northeastern New York" with 4 trials sponsored, "Biogen" with 3 trials sponsored, "JANSSEN Alzheimer Immunotherapy Research & Development, LLC" with 3 trials sponsored and "Hoffmann-La Roche" with 3 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Empire Neurology, PC" #1 collaborator was "Pfizer" with 3 trials as a collaborator, "Biogen" with 2 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "EMD Serono" with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Empire Neurology, PC" are "Alzheimer's Disease" (10 trials), "Multiple Sclerosis" (9 trials), "Multiple Sclerosis, Relapsing-Remitting" (2 trials), "Alzheimer´s Disease" (1 trials) and "Multiple Sclerosis, Primary Progressive" (1 trials). Many other conditions were trialed in "Empire Neurology, PC" in a lesser frequency.

Most popular intervention types in "Empire Neurology, PC" are "Drug" (22 trials), "Biological" (3 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Ocrelizumab" (4 trials), "Bapineuzumab 0.5 mg/kg" (2 trials), "Bapineuzumab 1.0 m/kg" (2 trials) and "Interferon beta-1a" (2 trials). Other intervention names were less common.

The vast majority of trials in "Empire Neurology, PC" are 25 trials for "All" genders.

Currently, there are NaN active trials in "Empire Neurology, PC". undefined are not yet recruiting, 1 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Empire Neurology, PC, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Empire Neurology, PC, 2 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 0 trials that are defined as “Not Applicable".